| Literature DB >> 28211905 |
Willian Eiji Miyagi1,2, Rodrigo de Araujo Bonetti de Poli1,2, Marcelo Papoti3, Romulo Bertuzzi4, Alessandro Moura Zagatto1,2.
Abstract
The aim was to verify the validity (i.e., study A) and reliability (i.e., study B) of the alternative maximal accumulated oxygen deficit determined using onlya supramaximal effort (MAODALT)to estimate anaerobic capacity [i.e., estimated by the gold standard maximal accumulated oxygen deficit method (MAOD)] during cycling. In study A, the effects of supramaximal intensities on MAODALT and the comparison with the MAOD were investigated in fourteen active subjects (26 ± 6 years). In study B, the test-retest reliability was investigated, where fourteen male amateur cyclists (29 ± 5 years) performed the MAODALT twice at 115% of the intensity associated to maximal oxygen uptake (). MAODALT determined at 130 and 150% of was lower than MAOD (p ≤ 0.048), but no differences between MAODALT determined at 100, 105, 110, 115, 120 and 140% of (3.58 ± 0.53L; 3.58 ± 0.59L; 3.53 ± 0.52L; 3.48 ± 0.72L; 3.52 ± 0.61L and 3.46 ± 0.69L, respectively) with MAOD (3.99 ± 0.64L). The MAODALT determined from the intensities between 110 and 120% of presented the better agreement and concordance with MAOD. In the test-retest, the MAODALT was not different (p > 0.05), showed high reproducibility when expressed in absolute values (ICC = 0.96, p < 0.01), and a good level of agreement in the Bland-Altman plot analysis (mean differences ± CI95%:-0.16 ± 0.53L). Thus, the MAODALT seems to be valid and reliable to assess anaerobic capacity in cycling.Entities:
Year: 2017 PMID: 28211905 PMCID: PMC5304204 DOI: 10.1038/srep42485
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Physiological responses at exhaustion in the graded exercise test.
| RER | HRmax (bpm) | RPE | [La−]Peak (mmol·L−1) | Total time (min) | ||
|---|---|---|---|---|---|---|
| Study A | 43.4 ± 4.9 | 1.20 ± 0.06 | 183 ± 6 | 18 ± 1 | 11.1 ± 1.4 | 12.2 ± 2.5 |
| (n = 14) | (40.5 to 46.2) | (1.17 to 1.23) | (180 to 187) | (17 to 19) | (10.3 to 11.9) | (10.8 to 13.6) |
| Study B | 45.5 ± 7.4 | 1.21 ± 0.05 | 188 ± 9 | 18 ± 2 | 10.0 ± 2.1 | 12.8 ± 3.6 |
| (n = 11) | (40.5 to 50.5) | (1.17 to 1.25) | (181 to 194) | (17 to 20) | (8.5 to 11.5) | (10.4 to 15.3) |
Values presented as mean ± SD (CI95%). = maximal oxygen uptake. RER = respiratory exchange ratio. HRmax = maximal heart rate. RPE = rate of perceived exertion. [La−]Peak = peak lactate.
Intensity, time to exhaustion, oxygen equivalent of the glycolytic metabolism (E[La]), resting lactate ([La−]Rest), peak lactate ([La−]Peak), difference between [La−]Rest and [La−]Peak (Δ[La−]), oxygen equivalent of the phosphagen metabolism (EPCr), amplitude (A1), and time constant (τ1)of the bi-exponential adjustment obtained in the supramaximal efforts at 100, 105, 110, 115, 120, 130, 140, and 150% of the intensity associated with maximal oxygen uptake (MAODALT100, MAODALT105, MAODALT110, MAODALT115, MAODALT120, MAODALT130, MAODALT140, and MAODALT150).
| 100% | 105% | 110% | 115% | 120% | 130% | 140% | 150% | p-value | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Intensity (W) | 225.6 ± 34.1 (206.0 to 245.3) | 237.1 ± 35.8a (216.4 to 257.8) | 248.5 ± 37.4ab (226.9 to 270.1) | 259.6 ± 39.3abc (236.9 to 282.2) | 270.8 ± 40.9abcd (247.2 to 294.4) | 293.6 ± 44.2abcde (268.1 to 319.2) | 315.9 ± 47.7abcdef (288.4 to 343.5) | 338.8 ± 51.0abcdefg (309.3 to 368.2) | 620.62 | 0.000 |
| Time to exhaustion (min) | 5.22 ± 0.99 (4.65 to 5.79) | 4.24 ± 0.26a (3.81 to 4.68) | 3.66 ± 0.46a (3.39 to 3.92) | 3.15 ± 0.66ab (2.77 to 3.53) | 2.74 ± 0.56abc (2.42 to 3.07) | 2.09 ± 0.28abcde (1.93 to 2.25) | 1.83 ± 0.26abcde (1.68 to 1.98) | 1.59 ± 0.22abcdefg (1.46 to 1.72) | 109.60 | 0.000 |
| E[La] (L) | 2.30 ± 0.47 (2.03 to 2.57) | 2.32 ± 0.52 (2.02 to 2.62) | 2.28 ± 0.35 (2.08 to 2.48) | 2.22 ± 0.54 (1.91 to 2.53) | 2.31 ± 0.46 (2.05 to 2.48) | 2.11 ± 0.52 (1.80 to 2.41) | 2.21 ± 0.50 (1.92 to 2.50) | 2.20 ± 0.46 (1.94 to 2.46) | 0.92 | 0.493 |
| [La−]Rest (mmol·L−1) | 1.17 ± 0.30 (1.00 to 1.35) | 1.36 ± 0.41 (1.12 to 1.60) | 1.13 ± 0.32 (0.94 to 1.31) | 1.25 ± 0.28 (1.09 to 1.41) | 1.15 ± 0.27 (1.00 to 1.31) | 1.21 ± 0.32 (1.02 to 1.39) | 1.26 ± 0.36 (1.06 to 1.47) | 1.13 ± 0.17 (1.04 to 1.23) | 0.98 | 0.452 |
| [La−]Peak (mmol·L−1) | 11.71 ± 2.15 (10.47 to 12.95) | 11.89 ± 1.72 (10.90 to 12.88) | 11.51 ± 1.28 (10.78 to 12.25) | 11.33 ± 1.83 (10.27 to 12.39) | 11.71 ± 1.78 (10.69 to 12.74) | 10.69 ± 1.65 (9.73 to 11.64) | 11.30 ± 1.91 (10.19 to 12.40) | 11.08 ± 1.28 (10.34 to 11.82) | 1.21 | 0.308 |
| Δ[La−] (mmol·L−1) | 10.54 ± 2.08 (9.33 to 11.74) | 10.53 ± 1.75 (9.52 to 11.54) | 10.39 ± 1.18 (9.71 to 11.07) | 10.08 ± 1.93 (8.97 to 11.19) | 10.56 ± 1.92 (9.45 to 11.67) | 9.48 ± 1.63 (8.54 to 10.42) | 10.03 ± 1.87 (8.95 to 11.11) | 9.94 ± 1.27 (9.21 to 10.68) | 1.21 | 0.306 |
| EPCr (L) | 1.28 ± 0.20 (1.16 to 1.39) | 1.26 ± 0.22 (1.13 to 1.39) | 1.24 ± 0.28 (1.08 to 1.41) | 1.26 ± 0.29 (1.09 to 1.43) | 1.21 ± 0.27 (1.05 to 1.36) | 1.21 ± 0.27 (1.06 to 1.37) | 1.25 ± 0.28 (1.09 to 1.41) | 1.19 ± 0.29 (1.02 to 1.36) | 1.06 | 0.393 |
| A1 (mL·kg−1·min−1) | 19.3 ± 3.0 (17.5 to 21.0) | 19.3 ± 2.7 (17.7 to 20.8) | 18.0 ± 4.1 (15.6 to 20.4) | 18.6 ± 3.5 (16.6 to 20.6) | 18.3 ± 2.3 (16.9 to 19.6) | 17.7 ± 2.4 (16.4 to 19.1) | 17.9 ± 2.6 (16.4 to 19.4) | 17.4 ± 2.0 (16.3 to 18.6) | 1.52 | 0.225 |
| τ1 (min) | 0.92 ± 0.11 (0.85 to 0.98) | 0.90 ± 0.16 (0.81 to 0.99) | 1.01 ± 0.42 (0.77 to 1.26) | 0.94 ± 0.19 (0.83 to 1.05) | 0.90 ± 0.09 (0.85 to 0.95) | 0.93 ± 0.10 (0.87 to 0.99) | 0.95 ± 0.12 (0.88 to 1.02) | 0.93 ± 0.13 (0.85 to 1.00) | 0.53 | 0.811 |
Values presented as mean ± SD (IC95%). ap < 0.05 to 100% . bp < 0.05 to 105% . cp < 0.05 to 110% . dp < 0.05 to 115% . ep < 0.05 to 120% . fp < 0.05 to 130% . gp < 0.05 to 140% .
Figure 1Comparison of the maximal accumulated oxygen deficit determined by the conventional method (MAOD) and alternative method (MAODALT).
The MAODALT was determined at intensities of 100, 105, 110, 115, 120, 130, 140, and 150% of the intensity associated with maximal oxygen uptake (MAODALT100, MAODALT105, MAODALT110, MAODALT115, MAODALT120, MAODALT130, MAODALT140, and MAODALT150). The MAOD and MAODALT values are presented in absolute (A), relative to body mass (B), lean mass (LM) (C), and lean mass of lower limb values (LM-LL) (D). *p < 0.05 to MAOD.
Relationship and level of agreement between MAOD and MAODALT determined at different supramaximal efforts.
| MAODALT100 | MAODALT105 | MAODALT110 | MAODALT115 | MAODALT120 | MAODALT130 | MAODALT140 | MAODALT150 | ||
|---|---|---|---|---|---|---|---|---|---|
| MAOD (L) | Coefficient of correlation | 0.54* | 0.57* | 0.66** | 0.68** | 0.62* | 0.55* | 0.65* | 0.61* |
| (CI95%) | (0.01 to 0.83) | (0.06 to 0.85) | (0.20 to 0.88) | (0.24 to 0.89) | (0.14 to 0.87) | (0.03 to 0.84) | (0.18 to 0.88) | (0.12 to 0.86) | |
| Effect size | 0.71 | 0.67 | 0.80 | 0.75 | 0.75 | 1.03 | 0.80 | 0.96 | |
| Mean of differences (±CI95%) | −0.42 (0.33) | −0.42 (0.33) | −0.47 (0.28) | −0.52 (0.31) | −0.47 (0.32) | −0.68 (0.36) | −0.53 (0.32) | −0.61 (0.32) | |
| Typical error (L) | 0.41 | 0.40 | 0.35 | 0.39 | 0.39 | 0.44 | 0.40 | 0.39 | |
| MAOD (mL·kg−1) | Coefficient of correlation | 0.44 | 0.23 | 0.15 | 0.27 | 0.26 | −0.20 | 0.26 | −0.08 |
| (CI95%) | (−0.12 to 0.79) | (−0.34 to 0.68) | (−0.41 to 0.63) | (−0.30 to 0.70) | (−0.31 to 0.70) | (−0.66 to 0.37) | (−0.32 to 0.69) | (−0.58 to 0.47) | |
| Effect size | 0.85 | 0.97 | 1.18 | 1.13 | 1.03 | 1.78 | 1.14 | 1.78 | |
| Mean of differences (±CI95%) | −5.53 (3.99) | −5.76 (4.30) | −6.47 (4.22) | −7.26 (4.46) | −6.54 (4.44) | −9.69 (4.94) | −7.51 (4.63) | −8.69 (4.33) | |
| Typical error (mL·kg−1) | 4.89 | 5.27 | 5.17 | 5.46 | 5.44 | 6.05 | 5.67 | 5.30 | |
| MAOD (mL·kg−1 LM) | Coefficient of correlation | 0.51 | 0.31 | 0.30 | 0.45 | 0.43 | 0.07 | 0.48 | 0.33 |
| (CI95%) | (−0.02 to 0.82) | (−0.26 to 0.72) | (−0.28 to 0.72) | (−0.10 to 0.79) | (−0.13 to 0.78) | (−0.48 to 0.58) | (−0.07 to 0.80) | (−0.25 to 0.73) | |
| Effect size | 0.78 | 0.93 | 1.17 | 0.98 | 0.92 | 1.53 | 0.96 | 1.37 | |
| Mean of differences (±CI95%) | −7.39 (5.41) | −7.77 (7.08) | −8.72 (5.51) | −9.54 (5.87) | −8.65 (5.85) | −12.82 (6.68) | −9.78 (6.06) | −11.39 (5.71) | |
| Typical error (mL·kg−1 LM) | 6.63 | 7.08 | 6.75 | 7.19 | 7.16 | 8.18 | 7.42 | 7.00 | |
| MAOD (mL·kg−1 LM-LL) | Coefficient of correlation | 0.62* | 0.46 | 0.42 | 0.55* | 0.51 | 0.18 | 0.58* | 0.34 |
| (CI95%) | (0.13 to 0.87) | (−0.10 to 0.80) | (−0.14 to 0.78) | (0.04 to 0.84) | (−0.03 to 0.82) | (−0.39 to 0.65) | (0.08 to 0.85) | (−0.23 to 0.74) | |
| Effect size | 0.71 | 0.81 | 1.03 | 0.90 | 0.85 | 1.45 | 0.89 | 1.36 | |
| Mean of differences (±CI95%) | −20.87 (14.78) | −21.89 (16.30) | −24.90 (15.54) | −27.09 (16.52) | −24.67 (16.56) | −36.95 (19.05) | −27.87 (16.84) | −33.00 (16.56) | |
| Typical error (mL·kg−1 LM-LL) | 18.10 | 19.97 | 19.03 | 20.23 | 20.28 | 23.33 | 20.63 | 20.27 |
*p < 0.05. **p < 0.01. LM-LL = lean mass of lower limbs.
Time to exhaustion, alternative maximal accumulated oxygen deficit (MAODALT), oxygen equivalents from the glycolytic (E[La]) and phosphagen metabolisms (EPCr) determined in the test and retest condition (n = 14).
| Test | Retest | ES | CV | ICC (CI95%) | ||
|---|---|---|---|---|---|---|
| Time to exhaustion (s) | 182.1 ± 16.2 (171.2 to 193.0) | 180.7 ± 25.2 (163.8 to 197.7) | −0.06 | 4.5% | 0.708 | 0.81¥ (0.43 to 0.94) |
| MAODALT (L) | 4.42 ± 0.92 (3.80 to 5.03) | 4.58 ± 0.96 (3.94 to 5.23) | 0.17 | 4.1% | 0.075 | 0.96¥ (0.85 to 0.99) |
| MAODALT (mL·kg−1) | 52.2 ± 7.5 (47.1 to 57.2) | 54.1 ± 8.2 (48.5 to 59.6) | 0.24 | 4.1% | 0.082 | 0.92¥ (0.72 to 0.98) |
| MAODALT (mL·kg−1 LM) | 70.0 ± 8.7 (64.1 to 75.8) | 72.5 ± 9.5 (66.1 to 78.8) | 0.27 | 4.1% | 0.086 | 0.89¥ (0.63 to 0.97) |
| MAODALT (mL·kg−1 LM-LL) | 197.1 ± 23.2 (181.5 to 212.7) | 204.2 ± 26.2 (186.7 to 221.8) | 0.55 | 4.1% | 0.085 | 0.87# (0.60 to 0.96) |
| E[La] (L) | 2.76 ± 0.56 (2.39 to 3.14) | 2.77 ± 0.63 (2.35 to 3.19) | 0.01 | 4.9% | 0.896 | 0.92¥ (0.75 to 0.98) |
| [La−]Rest (mmol·L−1) | 1.1 ± 0.2 (0.9 to 1.2) | 1.0 ± 0.3 (0.9 to 1.2) | −0.40 | 18.5% | 0.666 | 0.16 (−0.46 to 0.67) |
| [La−]Peak (mmol·L−1) | 12.0 ± 1.7 (10.9 to 13.2) | 12.0 ± 2.0 (10.6 to 13.4) | 0.00 | 4.6% | 0.882 | 0.89¥ (0.64 to 0.97) |
| Δ[La−] (mmol·L−1) | 10.9 ± 1.7 (9.8 to 12.1) | 11.0 ± 1.9 (9.7 to 12.2) | 0.05 | 5.3% | 0.973 | 0.88¥ (0.62 to 0.97) |
| EPCr (L) | 1.64 ± 0.44 (1.34 to 1.93) | 1.79 ± 0.51 (1.45 to 2.14) | 0.31 | 12.1% | 0.210 | 0.68¥ (0.17 to 0.90) |
| A1 (mL·kg−1·min−1) | 19.4 ± 3.0 (17.3 to 21.4) | 19.6 ± 3.6 (17.2 to 22.2) | 0.66 | 5.9% | 0.794 | 0.71¥ (0.24 to 0.91) |
| Time constant (min) | 1.00 ± 0.21 (0.87 to 1.14) | 1.09 ± 0.20 (0.95 to 1.22) | 0.43 | 14.2% | 0.309 | 0.21 (−0.41 to 0.70) |
Values presented as mean ± SD. *p < 0.05 to test condition. #p < 0.05. ¥p < 0.01. [La−]Rest = resting lactate. [La−]Peak = peak lactate. (ES = effect size; ICC = intraclass correlation coefficient).
Figure 2Bland-Altman plot analysis with MAODALT determined in test and retest.
The MAODALT values expressed in absolute (A), relative to body mass (B), lean mass (C), and lean mass of lower limb values (D).
Characteristics of the participants.
| Age (years) | Height (cm) | Body Mass (kg) | Lean Mass* (kg) | Fat* (%) | LM-LL* (kg) | |
|---|---|---|---|---|---|---|
| Study A (n = 14) | 26 ± 6 | 172.4 ± 5.4 | 73.8 ± 10.8 | 55.4 ± 6.4 | 19.4 ± 4.5 | 19.1 ± 2.4 |
| Study B (n = 11) | 28 ± 4 | 177.0 ± 5.8 | 85.2 ± 16.1 | 63.2 ± 11.0 | 20.5 ± 4.8 | 22.5 ± 4.4 |
Values presented as mean ± SD. BM = Body mass. LM = lean mass. LM-LL = lean mass of the lower limbs. = maximal oxygen uptake. *Estimated by the dual-energy X-ray absorptiometry method.
Figure 3Supramaximal oxygen uptake () estimated at 110% of the intensity associated with the maximal oxygen uptake () (A) and the maximal accumulated oxygen deficit (MAOD) (B).